Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer 09 March
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity 05 March
New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools 05 March
